L2P Research (@l2plabs) Bsky

Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies GOTHENBURG, Sweden, April 23, 2026 /PRNewswire/ -- First quarter Sales of SEK 807 (842) million, an increase of 5% in local currencies and 4% decrease in SEK. Sales per region, in local currencies, were -1% in EMEA, +11% in Americas and +7% in APAC. Sales per product group, in local...

1 hour ago 0 0 0 0

PrecisionBiotics® (Novonesis) and Biocodex Mark Next Phase of Strategic Partnership with New Agreement COPENHAGEN, Denmark, April 23, 2026 /PRNewswire/ -- PrecisionBiotics®, part of Novonesis, and Biocodex have formalised the next phase of their partnership at a strategic leadership meeting with the signing of a new agreement that will further strengthen collaboration between the two...

1 hour ago 0 0 0 0

Essity: Interim Report Quarter 1, 2026 Good start to 2026 – increased volumes and higher margins STOCKHOLM, April 23, 2026 /PRNewswire/ -- Quarter 1, 2026 Net sales decreased 5.1% to SEK 33,177m (34,976). Excluding currency translation effects, net sales increased SEK 528m. Organic sales growth amounted to 0.4%, of which...

1 hour ago 0 0 0 0

New release 'The Doctor's Future' warns physicians to lead, not fear, the rise of artificial intelligence and robotics in healthcare Dr. Pietro Emanuele Garbelli presents a blueprint to future-proof medicine in an AI-driven era LONDON, April 23, 2026 /PRNewswire/ -- From the author of the award-winning "The Doctor's Voice" comes another visionary work that seeks to empower healthcare decision-makers, policy leaders and...

4 hours ago 0 0 0 0

AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches SAN DIEGO, April 22, 2026 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) announced that the company presented six latest preclinical and translational research findings in poster sessions at the American Association for Cancer Research (AACR) Annual Meeting, held from April 17 to 22,...

4 hours ago 0 0 0 0

Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT Gastric cancer (GC) continues to pose significant challenges in the field of Oncology, particularly in its advanced stages. According to GLOBOCAN, approximately 970,000 new cases of GC were diagnosed globally in 2022, constituting about 4.9% of all cancer cases. Moreover, GC accounted for approximately 660,000 deaths, representing 6.8% of all cancer-related deaths worldwide. Therefore, GC ranks as the fifth most diagnosed cancer and the fifth leading cause of cancer mortality globally. Its incidence exhibits notable geographic variability, with substantially higher rates in East and Southeast Asia compared to Europe and the United States [1], highlighting the need for globally representative studies rather than those focused solely on Western or Asian populations.

4 hours ago 0 0 0 0

Accelerating drug discovery with fragment screening Modern medicine has played a significant role in improving the length and quality of our lives. While many treatments may seem like miracles, they are the result of a lengthy, rigorous research process. Drug discovery is a particularly time-consuming and costly activity that is fraught with complex challenges and labor-intensive bouts of trial and error.

5 hours ago 0 0 0 0

Genomma Lab Internacional Announces Results for the First Quarter 2026 MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance...

7 hours ago 0 0 0 0

Chicken gene-editing advance opens path to drug-producing eggs Chicken eggs are already used to harvest helpful proteins called antibodies to protect humans from viruses such as influenza. Now, a breakthrough at the University of Missouri could one day lead to chickens that produce other useful medical proteins in their eggs.

8 hours ago 0 0 0 0

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price...

8 hours ago 0 0 0 0

Cosmetics from waste? Microbial discovery unlocks greener route to high-value chemical products Researchers at University of Toronto's Department of Chemical Engineering & Applied Chemistry have made a key discovery about how certain bacterial strains produce a set of economically valuable chemicals—opening the door to new, more sustainable production methods. The finding, published in Nature Microbiology, shows how a family of molecules used in everything from cleaning products to cosmetics to nutritional supplements could be made via bacterial fermentation instead of from palm oil, as they are today.

9 hours ago 0 0 0 0

RhythMedix Launches Next-Generation RhythmStar® SL Cardiac Monitor Advancing Remote Cardiac Monitoring with Faster Insights, Greater Comfort, and Seamless Connectivity MOUNT LAUREL, N.J., April 22, 2026 /PRNewswire/ -- RhythMedix, LLC (RhythMedix), a nationwide U.S.-based cardiac monitoring company, today announced the launch of its next-generation...

9 hours ago 0 0 0 0

Human Drug Compounding Compounded drugs can serve an important medical need for certain patients, they also present a risk to patients.

9 hours ago 0 0 0 0

How a faster protein-screening tool could strengthen US rare-earth supply chains To ensure a robust domestic supply chain in the U.S., Lawrence Livermore National Laboratory (LLNL) scientists are using bacterial proteins to separate the rare-earth elements that are ubiquitous in magnets, batteries, and electronics. These proteins, called lanmodulin, evolved in bacteria that use rare-earth elements to power their metabolism. But to scale up and advance biomining technology, researchers need a faster way to find and design better proteins.

9 hours ago 0 0 0 0

FDA notification regarding dehydrated alcohol FDA notification regarding dehydrated alcohol

10 hours ago 0 0 0 0

GDUFA III Drug Master File (DMF) Review Enhancements Effective communication among ANDA applicants, DMF holders, and FDA is essential for reducing the likelihood of potential problems that could delay approvals.

11 hours ago 0 0 0 0

Regulatory Science Forum with Dr. Alison Bateman-House Virtual via Zoom Tuesday, May 19, 2026, 12 – 1pm The Harvard-MIT Center for Regulatory Science is delighted to invite you to the upcoming Regulatory Science Forum, which will take place on May 19th via Zoom at 12 PM EST. We are excited to welcome Alison Bateman-House, Associate Professor, Department of Population Health, Section of Medical Ethics, NYU Grossman School of Medicine. She will address the topic: “Accessing drugs in development: clinical trials, expanded access, and right to try” - Candidate drugs are not available for widespread use until and unless they receive marketing authorization. Or are they? We will discuss that statement in several settings (e.g., public health emergencies, rare diseases) and identify how diverse stakeholders (e.g., sponsors, patient advocates) have sought to use different aspects of drug development (e.g., data collection, trial design, public hearings) to increase the likelihood of their preferred outcomes of interest, sometimes with unattended consequences. Join us over Zoom for an engaging presentation, and an opportunity to take part in the subsequent discussion. Topics: Pediatrics, Population Medicine Event Types: Forum Location: Harvard Medical School RSVP Required: Yes More info: harvard.zoom.us…

11 hours ago 0 0 0 0

Harvard Alumni Launch Lab X Info Session Virtual Tuesday, April 28, 2026, 3 – 4pm Topics: Administrative, Alumni Association, Anesthesia, Biochemistry, Biomedical Science, Biostatistics, Cardiology, Community, Dermatology, Diversity, Education, Endocrine, Epidemiology, Ethics, Genetics, GI/Nutrition, Immunology, LGBT, Longwood Seminars / Mini Med School, Medicine, Molecular Biology, Molecular Genetics, Neurology, Nuclear Medicine, Obstetrics, Gynecology and Reproductive Biology, Oncology, Ophthalmology, Oral Health, Orthopedic Surgery, Otology-Laryngology, Pediatrics, Physical Medicine & Rehabilitation, Population Medicine, Psychiatry, Public Health, Radiation Oncology, Radiology, Surgery, Sustainability, Vascular Biology, Virology, Wellness/Worklife Event Types: Webinar Location: Other RSVP Required: Yes More info: www.eventbrite.com…

11 hours ago 0 0 0 0

GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists PISCATAWAY, N.J., April 22, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the Entrepreneur Of The Year® 2026 New Jersey Award by Ernst & Young LLP. The Entrepreneur Of The Year...

12 hours ago 0 0 0 0

Stay Informed about Small Business Stay Informed about Small Business

12 hours ago 0 0 0 0

Engineered soil bacterial protein kills colorectal cancer cells by targeting their mitochondria Researchers at Umeå University have turned a protein from soil bacteria into a potential new weapon against colorectal cancer. Their study published in Cell Death Discovery shows how an engineered bacterial protein can trigger a unique form of cancer cell death.

12 hours ago 0 0 0 0

Hammes ranked as nation's No. 1 developer in annual Outpatient Real Estate Development Report MILWAUKEE, April 22, 2026 /PRNewswire/ -- Hammes, a national real estate consulting, development, investment and management firm, has been ranked as the nation's No. 1 outpatient healthcare developer based on 2025 activity in the 2026 Outpatient Real Estate Development Report. The annual...

15 hours ago 0 0 0 0

HOUSING WORKS CHOSEN AS 2026 BENEFICIARY OF 45TH ANNUAL FRONT RUNNERS NEW YORK LGBTQ+ PRIDE RUN™ 4M JUNE 27 RACE IN CENTRAL PARK WILL RAISE FUNDS FOR HOUSING WORKS' LIFESAVING SERVICES + ADVOCACY NEW YORK, April 22, 2026 /PRNewswire/ -- Housing Works is proud to announce that it was selected as the beneficiary of the 2026 Front Runners New York LGBTQ+ Pride Run™ 4M hosted by the Front...

16 hours ago 0 0 0 0

FDA PreCheck Pilot Program Structure Detailed information for the FDA Manufacturing PreCheck Pilot Program

16 hours ago 0 0 0 0

List of Drug Master Files (DMFs) The list is updated quarterly. Changes are made to the DMF activity status, DMF type, holder name, and subject.

16 hours ago 0 0 0 0

Brain Support Cells Form Previously Unknown Network Discovery offers new view of how the brain communicates NEW YORK, April 22, 2026 /PRNewswire/ -- Cells long thought to play a secondary role in brain function build their own far-reaching connections, a new study in mice showed. These pathways appear to connect distant regions in ways...

17 hours ago 0 0 0 0

Pulmonary Fibrosis Foundation Expands Leadership To Drive Scientific and Partnership Strategy Jessica Shore, PhD, RN, named Chief Scientific Officer; Jennifer Mefford named Chief Partnerships Officer CHICAGO, April 22, 2026 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) has appointed Jessica Shore, PhD, RN, as Chief Scientific Officer and Jennifer Mefford as Chief...

17 hours ago 0 0 0 0

Los Angeles Residents to Gain Faster Access to New Affordable Housing through Health Net's $10 Million Investment in "Guarantee Fund" Partnership with LA4LA will accelerate construction of affordable and mixed-use housing across LA County SACRAMENTO, Calif., April 22, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a Centene Corporation (NYSE: CNC) company,...

17 hours ago 0 0 0 0

Momcozy Partners with Postpartum Support International for Mother's Day Campaign Together Momcozy and PSI Debut the Truths of Motherhood Report and Giveback Initiative LOS ANGELES, April 22, 2026 /PRNewswire/ -- This Mother's Day, Momcozy, a leading global brand for maternal wellness, is partnering with Postpartum Support International (PSI), the leading perinatal...

17 hours ago 0 0 0 0

H.I.G. Capital Announces the Sale of Celerion MIAMI, April 22, 2026 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that one of its affiliates has signed a definitive agreement to sell its portfolio company, Celerion Holdings,...

17 hours ago 0 0 0 0

Posts by L2P Research